SEC Filings
Filing date | Form | Description | View |
---|---|---|---|
3 | Initial filing by director officer or owner of more than ten percent |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
8-K/A | Amendment to a previously filed 8-K |
View HTML | |
4 | Statement of changes in beneficial ownership of securities |
View HTML | |
SC TO-I/A | Amendment to a previously filed SC TO-I |
View HTML | |
SC TO-I/A | Amendment to a previously filed SC TO-I |
View HTML | |
8-K | Report of unscheduled material events or corporate event |
View HTML | |
SC TO-I/A | Amendment to a previously filed SC TO-I |
View HTML | |
8-K | Report of unscheduled material events or corporate event |
View HTML | |
SC 13G | A statement of beneficial ownership of common stock by certain persons |
View HTML |
Displaying 801 - 810 of 958 results
Data provided by Kaleidoscope.
For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.